EMA Reviews Experience With Deferring PIPs: Will it Result In Earlier Pediatric Trials?
Executive Summary
The European Medicines Agency is examining its current experience with granting deferrals for studies mandated under the EU Paediatric Regulation, and is re-considering when it is most appropriate to grant deferrals for neonatal studies.